MHTX — Manhattan Scientifics Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro CapSucker Stock
- $3.86m
- $4.77m
- $0.05m
Annual cashflow statement for Manhattan Scientifics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.55 | -8.33 | -1.22 | 4.31 | -3.64 |
Depreciation | |||||
Non-Cash Items | -3.82 | 6.89 | 0.564 | -4.96 | 3.05 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.629 | 0.144 | 0.34 | 0.26 | 0.168 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -0.791 | -0.682 | -0.316 | -0.388 | -0.421 |
Capital Expenditures | -0.008 | 0 | — | -0.004 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 0.5 | 0.34 | 0.484 | 0.3 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Cash from Investing Activities | -0.008 | 0.5 | 0.34 | 0.48 | 0.3 |
Financing Cash Flow Items | — | 0 | — | — | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 0 | 0.15 | 0 | 0 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.799 | -0.182 | 0.174 | 0.092 | -0.121 |